|
Brian Wynne, MD is Vice President of Clinical Development and Medical Affairs. While at GlaxoSmithKline, he led the clinical development of several pediatric and adult antibiotics, as well as the early phases of a novel topical antibiotic. Dr. Wynne's work at GSK ranged from early stage and discovery teams to leading the design, conduction, analysis and reporting of several pivotal studies, which led to successful registration and licensing of both antibiotic and antimalarial drugs. Dr. Wynne was the medical monitor for several phase 1 studies, for both antibiotic and antimalarial drugs.Dr. Wynne volunteers his time as an attending physician in the HIV clinic at Hahnemann University, and teaches Infectious Disease Fellows. Dr. Wynne is a graduate of The Medical College of Ohio, and completed residency in Internal Medicine at the Northeast Ohio University College of Medicine / The Akron City Hospital. After residency, he practiced clinical and academic medicine for 5 years. Following this, he completed a fellowship in Infectious Diseases at the Medical College of Pennsylvania. | 